Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

NCT04396067 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Aerosolized 13 cis retinoic acid
DRUG: Aerosolized All trans retinoic acid
OTHER: Placebo

Sponsor

Kafrelsheikh University

Collaborators

[object Object]